These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 24344665)

  • 41. Obesity and cardiovascular outcomes: a review.
    Ghoorah K; Campbell P; Kent A; Maznyczka A; Kunadian V
    Eur Heart J Acute Cardiovasc Care; 2016 Feb; 5(1):77-85. PubMed ID: 24526749
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The effects of physical activity and body mass index on cardiovascular, cancer and all-cause mortality among 47 212 middle-aged Finnish men and women.
    Hu G; Tuomilehto J; Silventoinen K; Barengo NC; Peltonen M; Jousilahti P
    Int J Obes (Lond); 2005 Aug; 29(8):894-902. PubMed ID: 15724141
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of body mass index, physical activity, and other clinical factors on cardiorespiratory fitness (from the Cooper Center longitudinal study).
    Lakoski SG; Barlow CE; Farrell SW; Berry JD; Morrow JR; Haskell WL
    Am J Cardiol; 2011 Jul; 108(1):34-9. PubMed ID: 21529738
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Class I obesity is paradoxically associated with decreased risk of postoperative stroke after carotid endarterectomy.
    Jackson RS; Black JH; Lum YW; Schneider EB; Freischlag JA; Perler BA; Abularrage CJ
    J Vasc Surg; 2012 May; 55(5):1306-12. PubMed ID: 22542344
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The impact of obesity on heart failure.
    Zhai AB; Haddad H
    Curr Opin Cardiol; 2017 Mar; 32(2):196-202. PubMed ID: 28092289
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Obesity paradoxes.
    McAuley PA; Blair SN
    J Sports Sci; 2011 May; 29(8):773-82. PubMed ID: 21416445
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Moderate overweight is beneficial and severe obesity detrimental for patients with documented atherosclerotic heart disease.
    Azimi A; Charlot MG; Torp-Pedersen C; Gislason GH; Køber L; Jensen LO; Thayssen P; Ravkilde J; Tilsted HH; Lassen JF; Thuesen L
    Heart; 2013 May; 99(9):655-60. PubMed ID: 23335496
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perils of weight loss: the advantage of being obese in patients with heart failure.
    Kydd A; Pugh PJ
    Expert Rev Cardiovasc Ther; 2009 Mar; 7(3):263-7. PubMed ID: 19296763
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Obesity and Heart Failure: Focus on the Obesity Paradox.
    Carbone S; Lavie CJ; Arena R
    Mayo Clin Proc; 2017 Feb; 92(2):266-279. PubMed ID: 28109619
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The concept of normal weight obesity.
    Oliveros E; Somers VK; Sochor O; Goel K; Lopez-Jimenez F
    Prog Cardiovasc Dis; 2014; 56(4):426-33. PubMed ID: 24438734
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Obesity and cardiovascular disease: pathogenic mechanisms and potential benefits of weight reduction.
    Douketis JD; Sharma AM
    Semin Vasc Med; 2005 Feb; 5(1):25-33. PubMed ID: 15968577
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The "obesity paradox": does it persist among Israeli patients with decompensated heart failure? A subanalysis of the Heart Failure Survey in Israel (HFSIS).
    Schwartzenberg S; Benderly M; Malnick S; George J; Goland S
    J Card Fail; 2012 Jan; 18(1):62-7. PubMed ID: 22196843
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The association between obesity, mortality and filling pressures in pulmonary hypertension patients; the "obesity paradox".
    Zafrir B; Adir Y; Shehadeh W; Shteinberg M; Salman N; Amir O
    Respir Med; 2013 Jan; 107(1):139-46. PubMed ID: 23199841
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Obesity and the Obesity Paradox in Heart Failure.
    Horwich TB; Fonarow GC; Clark AL
    Prog Cardiovasc Dis; 2018; 61(2):151-156. PubMed ID: 29852198
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Does body mass index really matter in the management of heart failure?: a review of the literature.
    Sagar UN; Ahmed MM; Adams S; Whellan DJ
    Cardiol Rev; 2008; 16(3):124-8. PubMed ID: 18414183
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Association of morbid obesity and weight change over time with cardiovascular survival in hemodialysis population.
    Kalantar-Zadeh K; Kopple JD; Kilpatrick RD; McAllister CJ; Shinaberger CS; Gjertson DW; Greenland S
    Am J Kidney Dis; 2005 Sep; 46(3):489-500. PubMed ID: 16129211
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Obesity, health status, and 7-year mortality in percutaneous coronary intervention: in search of an explanation for the obesity paradox.
    Younge JO; Damen NL; van Domburg RT; Pedersen SS
    Int J Cardiol; 2013 Aug; 167(4):1154-8. PubMed ID: 22475846
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Body habitus in heart failure: understanding the mechanisms and clinical significance of the obesity paradox.
    Parto P; Lavie CJ; Arena R; Bond S; Popovic D; Ventura HO
    Future Cardiol; 2016 Nov; 12(6):639-653. PubMed ID: 27762638
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.
    Lavie CJ; Milani RV; Ventura HO
    J Am Coll Cardiol; 2009 May; 53(21):1925-32. PubMed ID: 19460605
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Impact of obesity on cardiovascular disease.
    Zalesin KC; Franklin BA; Miller WM; Peterson ED; McCullough PA
    Endocrinol Metab Clin North Am; 2008 Sep; 37(3):663-84, ix. PubMed ID: 18775358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.